vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.1倍（$541.2M vs $487.7M），Privia Health Group, Inc.净利率更高（1.7% vs -10.1%，领先11.8%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 17.4%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 14.2%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
CLOV vs PRVA — 直观对比
营收规模更大
PRVA
是对方的1.1倍
$487.7M
营收增速更快
CLOV
高出27.3%
17.4%
净利率更高
PRVA
高出11.8%
-10.1%
两年增速更快
CLOV
近两年复合增速
14.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $541.2M |
| 净利润 | $-49.3M | $9.2M |
| 毛利率 | — | — |
| 营业利润率 | -10.1% | 2.1% |
| 净利率 | -10.1% | 1.7% |
| 营收同比 | 44.7% | 17.4% |
| 净利润同比 | -123.2% | 108.0% |
| 每股收益（稀释后） | — | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVPRVA
| Q4 25 | $487.7M | $541.2M | ||
| Q3 25 | $496.6M | $580.4M | ||
| Q2 25 | $477.6M | $521.2M | ||
| Q1 25 | $462.3M | $480.1M | ||
| Q4 24 | $337.0M | $460.9M | ||
| Q3 24 | $331.0M | $437.9M | ||
| Q2 24 | $356.3M | $422.3M | ||
| Q1 24 | $346.9M | $415.2M |
净利润CLOVPRVA
| Q4 25 | $-49.3M | $9.2M | ||
| Q3 25 | $-24.4M | $6.9M | ||
| Q2 25 | $-10.6M | $2.7M | ||
| Q1 25 | $-1.3M | $4.2M | ||
| Q4 24 | $-22.1M | $4.4M | ||
| Q3 24 | $-9.2M | $3.5M | ||
| Q2 24 | $7.4M | $3.5M | ||
| Q1 24 | $-19.2M | $3.0M |
毛利率CLOVPRVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 23.6% | — |
营业利润率CLOVPRVA
| Q4 25 | -10.1% | 2.1% | ||
| Q3 25 | -4.9% | 2.5% | ||
| Q2 25 | -2.2% | 0.6% | ||
| Q1 25 | -0.3% | 1.1% | ||
| Q4 24 | -6.4% | 1.1% | ||
| Q3 24 | -2.7% | 1.3% | ||
| Q2 24 | 2.0% | 1.2% | ||
| Q1 24 | -6.5% | 0.2% |
净利率CLOVPRVA
| Q4 25 | -10.1% | 1.7% | ||
| Q3 25 | -4.9% | 1.2% | ||
| Q2 25 | -2.2% | 0.5% | ||
| Q1 25 | -0.3% | 0.9% | ||
| Q4 24 | -6.6% | 1.0% | ||
| Q3 24 | -2.8% | 0.8% | ||
| Q2 24 | 2.1% | 0.8% | ||
| Q1 24 | -5.5% | 0.7% |
每股收益（稀释后）CLOVPRVA
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $479.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $308.7M | $737.2M |
| 总资产 | $541.0M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVPRVA
| Q4 25 | $78.3M | $479.7M | ||
| Q3 25 | — | $441.4M | ||
| Q2 25 | — | $390.1M | ||
| Q1 25 | — | $469.3M | ||
| Q4 24 | $194.5M | $491.1M | ||
| Q3 24 | $288.0M | $422.0M | ||
| Q2 24 | $254.8M | $387.4M | ||
| Q1 24 | $208.3M | $351.1M |
股东权益CLOVPRVA
| Q4 25 | $308.7M | $737.2M | ||
| Q3 25 | $340.9M | $709.1M | ||
| Q2 25 | $344.2M | $682.9M | ||
| Q1 25 | $336.1M | $659.4M | ||
| Q4 24 | $341.1M | $635.2M | ||
| Q3 24 | $342.2M | $614.9M | ||
| Q2 24 | $324.9M | $595.4M | ||
| Q1 24 | $292.5M | $576.8M |
总资产CLOVPRVA
| Q4 25 | $541.0M | $1.4B | ||
| Q3 25 | $559.7M | $1.4B | ||
| Q2 25 | $575.0M | $1.3B | ||
| Q1 25 | $583.7M | $1.2B | ||
| Q4 24 | $580.7M | $1.1B | ||
| Q3 24 | $653.0M | $1.1B | ||
| Q2 24 | $674.2M | $1.1B | ||
| Q1 24 | $671.8M | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | — |
| 自由现金流率自由现金流/营收 | -14.1% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 13.93× |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVPRVA
| Q4 25 | $-66.9M | $127.5M | ||
| Q3 25 | $12.1M | $52.0M | ||
| Q2 25 | $5.4M | $8.0M | ||
| Q1 25 | $-16.3M | $-24.1M | ||
| Q4 24 | $34.8M | $74.8M | ||
| Q3 24 | $50.0M | $33.2M | ||
| Q2 24 | $44.8M | $34.5M | ||
| Q1 24 | $25.9M | $-33.1M |
自由现金流CLOVPRVA
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | — | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $49.6M | — | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | — |
自由现金流率CLOVPRVA
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | — |
资本支出强度CLOVPRVA
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率CLOVPRVA
| Q4 25 | — | 13.93× | ||
| Q3 25 | — | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | — | -5.70× | ||
| Q4 24 | — | 17.00× | ||
| Q3 24 | — | 9.38× | ||
| Q2 24 | 6.04× | 9.94× | ||
| Q1 24 | — | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
